CGEM Cullinan Therapeutics, Inc. - Common Stock
$20,72
Kurs · Aug 18, 2026
Fundamentaldaten per Aug 6, 2026
52W-Spanne
$6–$21
98% of range
Analystenbewertung
STRONG BUY
19 analysts
Kursziel
$32
+53% upside
P/E (TTM)
-6.5
ROE
-44.0%
Nettogewinnmarge
—
CGEM Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$20.71
Marktkapitalisierung
$1.25B
P/E (TTM)
-6.5
EPS (TTM)
$-3.69
Umsatz (TTM)
—
Dividendenrendite
—
ROE
-44.0%
Verschuldungsgrad
—
52W-Spanne
$6 – $21
CGEM Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
—
2020-12-31
→
2022-12-31
EPS
$-3.69
2021-12-31
→
2023-12-31
Freier Cashflow
$-176M
2022-12-31
→
2025-12-31
Margen
—
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
CGEM
Peer-Median
P/E (TTM)
-6.5
—
P/B (K/B)
3.1
5.2
Price / FCF (Kurs / FCF)
-7.1
—
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
CGEM
Peer-Median
ROA
-41.1%
-44.7%
ROE
-44.0%
-51.5%
ROIC
-59.1%
—
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
CGEM
Peer-Median
Current Ratio (Liquiditätsgrad)
10.2
9.5
Quick Ratio
10.0
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
CGEM
Peer-Median
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
CGEM
Peer-Median
CGEM Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
19 Analysten
- Starker Kauf 9 47,4%
- Kauf 9 47,4%
- Halten 1 5,3%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
11 Analysten · 2026-08-14
Median
$30.00
Mittelwert
$31.73
← Unter allen Zielen
$20.71
Tief
$23.00
Hoch
$39.00
Median-Ziel
$30.00
+44,8%
Mittelwert-Ziel
$31.73
+53,2%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
0.04%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 30. Juni 2026 | $-0.81 | $-0.83 | 0.02% |
| 31. März 2026 | $-0.75 | $-0.85 | 0.10% |
| 31. Dezember 2025 | $-0.77 | $-0.83 | 0.06% |
| 30. September 2025 | $-0.77 | $-0.98 | 0.21% |
| 30. Juni 2025 | $-1.07 | $-0.85 | -0.22% |
| 31. März 2025 | $-0.74 | $-0.82 | 0.08% |
| 31. Dezember 2024 | $-0.73 | $-0.77 | 0.04% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| CGEM | $624M | -3.2 | — | — | -44.0% | — |
| AVBP | $854M | -4.7 | — | — | -59.7% | — |
| PURR | — | — | — | — | — | — |
| ORIC | $806M | -5.6 | — | — | -36.5% | — |
| AKTS | — | — | — | — | — | — |
| NVAX | $1.09B | 2.6 | 64.7% | 39.2% | -977.1% | — |
| INBX | $1.15B | -8.7 | 550.0% | -10773.5% | -365.9% | — |
| GLUE | $1.03B | — | 63.5% | -31.2% | -15.4% | — |
| MGTX | $645M | -5.6 | 144.6% | -140.3% | 8062.2% | — |
| CRVS | $575M | -14.5 | — | — | -21.6% | — |
| MNKD | $1.75B | 283.5 | 22.2% | 1.7% | -11.1% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 15
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | $0 | $19M | $0 | |
| R&D Expense | $187M | $143M | $148M | $92M | $58M | $43M | |
| SG&A Expense | $54M | $54M | $42M | $40M | $29M | $17M | |
| Operating Expenses | $242M | $197M | $191M | $132M | $87M | $60M | |
| Operating Income | $-242M | $-197M | $-191M | $145M | $-68M | $-60M | |
| Interest Income | $22M | $30M | $22M | $7M | $477.0K | $888.0K | |
| Other Non-op | $-443.0K | $-199.0K | $239.0K | $57.0K | $-8.0K | $-11.0K | |
| Pretax Income | $-220M | $-167M | $-169M | $151M | $-67M | · | |
| Income Tax | $0 | $117.0K | $-14M | $42M | $0 | · | |
| Net Income | $-220M | $-167M | $-153M | $111M | $-66M | $-52M | |
| EPS (Basic) | · | · | $-3.69 | $2.46 | $-1.52 | · | |
| EPS (Diluted) | · | · | $-3.69 | $2.38 | $-1.52 | · | |
| Shares (Basic) | · | · | 41,550,000 | 45,164,000 | 43,077,000 | · | |
| Shares (Diluted) | · | · | 41,550,000 | 46,640,000 | 43,077,000 | · | |
| EBITDA | $-241M | $-197M | $-191M | $145M | $-68M | · |
Bilanz 21
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $88M | $83M | $98M | $156M | $60M | $168M | |
| Short-term Investments | $290M | $316M | $369M | $311M | $231M | $42M | |
| Prepaid Expense | $9M | $16M | $13M | $7M | $6M | $2M | |
| Other Current Assets | · | · | $4M | · | · | · | |
| Current Assets | $387M | $415M | $480M | $474M | $297M | $212M | |
| PP&E (Net) | $421.0K | $683.0K | $989.0K | $1M | $77.0K | $130.0K | |
| PP&E (Gross) | $1M | $1M | $1M | $1M | $309.0K | $309.0K | |
| Accum. Depreciation | $969.0K | $658.0K | $352.0K | $135.0K | $232.0K | $179.0K | |
| Other Non-current Assets | $297.0K | $366.0K | $459.0K | $459.0K | $147.0K | $2M | |
| Total Assets | $448M | $622M | $484M | $561M | $437M | $215M | |
| Accounts Payable | $841.0K | $2M | $2M | $3M | $3M | $10M | |
| Accrued Liabilities | $36M | $28M | $24M | $14M | $9M | $5M | |
| Current Liabilities | $38M | $31M | $28M | $22M | $12M | $14M | |
| Capital Leases | $2M | $849.0K | $2M | $4M | · | · | |
| Total Liabilities | $40M | $31M | $30M | $26M | $12M | $14M | |
| Common Stock | $6.0K | $6.0K | $4.0K | $5.0K | $4.0K | $3.0K | |
| Retained Earnings | $-588M | $-368M | $-201M | $-48M | $-159M | $-93M | |
| AOCI | $1M | $-133.0K | $-129.0K | $-3M | $-838.0K | $-2.0K | |
| Stockholders' Equity | $409M | $590M | $454M | $535M | $425M | $199M | |
| Liabilities + Equity | $448M | $622M | $484M | $561M | $437M | $215M | |
| Shares Outstanding | 60,244,136 | 58,510,610 | 42,900,083 | 45,796,449 | 44,292,102 | 29,831,125 |
Cashflow 13
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $311.0K | $306.0K | $310.0K | $93.0K | $53.0K | $62.0K | |
| Stock-based Comp | $36M | $38M | $30M | $28M | $24M | $15M | |
| Deferred Tax | · | $3M | $5M | · | $0 | $0 | |
| Other Non-cash | $8M | $-19M | $-17M | $-266M | $-2M | · | |
| Operating Cash Flow | $-176M | $-145M | $-134M | $-127M | $-43M | $-30M | |
| CapEx | $49.0K | $0 | $208.0K | $1M | $0 | $10.0K | |
| Investing Cash Flow | $180M | $-136M | $36M | $249M | $-334M | $-5M | |
| Stock Issued | $0 | $263M | $38M | $0 | $3M | $145M | |
| Stock Repurchased | · | · | · | · | · | $7M | |
| Net Stock Activity | $0 | $263M | $38M | $6M | · | · | |
| Financing Cash Flow | $1M | $266M | $41M | $-26M | $269M | $140M | |
| Taxes Paid | $-3M | $-2M | $-4M | $38M | $0 | · | |
| Free Cash Flow | $-176M | $-145M | $-134M | $-128M | · | · |
Rentabilität 6
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | -358.7% | · | |
| Net Margin | · | · | · | · | -346.1% | · | |
| EBITDA Margin | · | · | · | · | -358.4% | · | |
| ROA | -41.1% | -30.3% | -29.3% | 22.3% | -20.1% | · | |
| ROE | -44.0% | -32.1% | -31.0% | 23.2% | -21.0% | · | |
| ROIC | -59.1% | -33.4% | -38.6% | 19.5% | · | · |
Liquidität & Solvenz 2
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 10.2 | 13.5 | 17.1 | 21.1 | 25.2 | · | |
| Quick Ratio | 10.0 | 13.0 | 16.6 | 20.8 | 24.7 | · |
Effizienz 1
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | 0.0 | 0.1 | · |
Bewertung (TTM) 10
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | $0 | $0 | $19M | $0 | |
| Net Income TTM | $-220M | $-167M | $-153M | $111M | $-66M | $-52M | |
| Market Cap | $624M | $713M | $437M | $483M | $683M | · | |
| P/E | -3.2 | -3.8 | -2.8 | 4.4 | -10.2 | · | |
| P/S | · | · | · | · | 36.1 | · | |
| P/B | 1.5 | 1.2 | 1.0 | 0.9 | 1.6 | · | |
| P / Tangible Book | 1.5 | 1.2 | 1.0 | 0.9 | 1.6 | · | |
| P / Cash Flow | -3.5 | -4.9 | -3.3 | -3.8 | -15.7 | · | |
| P / FCF | -3.5 | -4.9 | -3.3 | -3.8 | · | · | |
| Earnings Yield | -31.0% | -26.4% | -36.2% | 22.6% | -9.8% | · |
Gewinn- und Verlustrechnung 15
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| R&D Expense | $44M | $42M | $43M | $42M | $61M | $41M | $40M | $36M | $36M | $31M | $35M | $34M | $27M | $52M | $21M | $20M | |
| SG&A Expense | $13M | $12M | $12M | $14M | $15M | $14M | $15M | $13M | $14M | $12M | $11M | $11M | $10M | $11M | $11M | $10M | |
| Operating Expenses | $57M | $54M | $55M | $56M | $76M | $55M | $55M | $49M | $50M | $43M | $45M | $45M | $38M | $63M | $33M | $30M | |
| Operating Income | $-57M | $-54M | $-55M | $-56M | $-76M | $-55M | $-55M | $-49M | $-50M | $-43M | $-45M | $-45M | $-38M | $-63M | $-33M | $-30M | |
| Interest Income | $4M | $4M | $5M | $5M | $6M | $7M | $8M | $8M | $8M | $6M | $6M | $6M | $5M | $5M | $3M | $2M | |
| Other Non-op | $-98.0K | $-62.0K | $-69.0K | $-108.0K | $-181.0K | $-85.0K | $6.0K | $-89.0K | $-72.0K | $-44.0K | $-117.0K | $180.0K | $69.0K | $107.0K | $298.0K | $0 | |
| Pretax Income | · | · | · | · | · | · | · | · | · | · | $-40M | $-39M | $-32M | $-58M | $-29M | $-27M | |
| Income Tax | · | · | · | · | · | · | · | · | · | · | $-14M | $0 | $0 | $0 | $-2M | $-3M | |
| Net Income | $-54M | $-50M | $-51M | $-51M | $-70M | $-49M | $-48M | $-41M | $-42M | $-37M | $-24M | $-39M | $-32M | $-58M | $-27M | $-25M | |
| EPS (Basic) | · | · | · | · | · | · | · | $-0.69 | $-0.75 | $-0.86 | · | $-0.91 | $-0.82 | $-1.42 | $-0.63 | $-0.54 | |
| EPS (Diluted) | · | · | · | · | · | · | · | $-0.69 | $-0.75 | $-0.86 | · | $-0.91 | $-0.82 | $-1.42 | $-0.58 | $-0.54 | |
| Shares (Basic) | · | · | · | · | · | · | · | 58,337,000 | 55,052,000 | 43,011,000 | · | 42,734,000 | 39,952,000 | 40,682,000 | -89,752,000 | 45,611,000 | |
| Shares (Diluted) | · | · | · | · | · | · | · | 58,337,000 | 55,052,000 | 43,011,000 | · | 42,734,000 | 39,952,000 | 40,682,000 | -89,784,000 | 45,611,000 | |
| EBITDA | $-57M | $-54M | · | $-56M | $-76M | $-55M | · | $-49M | $-50M | $-43M | · | $-45M | $-38M | $-63M | · | $-30M |
Bilanz 20
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $79M | $75M | $88M | $103M | $73M | $77M | $83M | $102M | $115M | $74M | $98M | $65M | $142M | $122M | $156M | $243M | |
| Short-term Investments | $256M | $277M | $290M | $229M | $193M | $227M | $316M | $476M | $547M | $359M | $369M | $402M | $350M | $269M | $311M | $333M | |
| Prepaid Expense | $7M | $10M | $9M | $10M | $10M | $14M | $16M | $14M | $15M | $13M | $13M | $619.0K | $619.0K | $8M | · | $619.0K | |
| Current Assets | $342M | $361M | $387M | $342M | $276M | $318M | $415M | $592M | $678M | $446M | $480M | $477M | $498M | $399M | $474M | $582M | |
| PP&E (Net) | $263.0K | $342.0K | $421.0K | $489.0K | $569.0K | $607.0K | $683.0K | $760.0K | $836.0K | $913.0K | $989.0K | $1M | $1M | $1M | $1M | $792.0K | |
| PP&E (Gross) | · | · | $1M | · | · | · | $1M | · | · | · | $1M | · | · | · | $1M | · | |
| Accum. Depreciation | · | · | $969.0K | · | · | · | $658.0K | · | · | · | $352.0K | · | · | · | $135.0K | · | |
| Other Non-current Assets | $297.0K | $297.0K | $297.0K | $361.0K | $367.0K | $366.0K | $366.0K | $460.0K | $460.0K | $460.0K | $459.0K | $459.0K | $459.0K | $459.0K | $459.0K | $460.0K | |
| Total Assets | $364M | $403M | $448M | $484M | $520M | $580M | $622M | $653M | $681M | $449M | $484M | $495M | $522M | $515M | $561M | $617M | |
| Accounts Payable | $4M | $3M | $841.0K | $2M | $2M | $3M | $2M | $2M | $2M | $4M | $2M | $951.0K | $2M | $2M | $3M | $2M | |
| Accrued Liabilities | $36M | $32M | $36M | $30M | $24M | $23M | $28M | $21M | $21M | $17M | $24M | $21M | $16M | $18M | $14M | $14M | |
| Current Liabilities | $41M | $35M | $38M | $33M | $28M | $27M | $31M | $24M | $23M | $22M | $28M | $23M | $20M | $26M | $22M | $27M | |
| Capital Leases | $1M | $2M | $2M | $0 | $125.0K | $493.0K | $849.0K | $1M | $2M | $2M | $2M | $2M | $3M | $3M | $4M | $4M | |
| Total Liabilities | $42M | $37M | $40M | $33M | $28M | $28M | $31M | $25M | $25M | $24M | $30M | $26M | $22M | $29M | $26M | $31M | |
| Common Stock | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $5.0K | $5.0K | |
| Retained Earnings | $-691M | $-638M | $-588M | $-537M | $-487M | $-417M | $-368M | $-321M | $-280M | $-238M | $-201M | $-177M | $-138M | $-106M | $-48M | $-21M | |
| AOCI | $-134.0K | $127.0K | $1M | $973.0K | $607.0K | $505.0K | $-133.0K | $970.0K | $-476.0K | $-331.0K | $-129.0K | $-1M | $-2M | $-1M | $-3M | $-4M | |
| Stockholders' Equity | $322M | $366M | $409M | $451M | $492M | $552M | $590M | $628M | $656M | $426M | $454M | $469M | $500M | $486M | $535M | $586M | |
| Liabilities + Equity | $364M | $403M | $448M | $484M | $520M | $580M | $622M | $653M | $681M | $449M | $484M | $495M | $522M | $515M | $561M | $617M | |
| Shares Outstanding | 64,345,770 | 61,451,380 | 60,244,136 | 59,076,259 | 59,074,391 | 58,698,919 | 58,510,610 | 58,141,130 | 57,871,638 | 43,065,645 | 42,900,083 | 42,760,644 | 42,735,304 | 39,343,601 | 45,796,449 | 45,743,027 |
Cashflow 12
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $79.0K | $79.0K | $79.0K | $79.0K | $77.0K | $76.0K | $77.0K | $76.0K | $77.0K | $76.0K | $77.0K | $80.0K | $81.0K | $72.0K | $59.0K | $9.0K | |
| Stock-based Comp | $8M | $8M | $7M | $9M | $10M | $9M | $10M | $9M | $11M | $8M | $8M | $8M | $8M | $7M | $8M | $5M | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | |
| Other Non-cash | · | $-4M | · | · | · | $-4M | · | · | · | $-9M | · | · | · | $-366.0K | · | · | |
| Operating Cash Flow | $-38M | $-46M | $-38M | $-37M | $-58M | $-43M | $-37M | $-34M | $-36M | $-38M | $-18M | $-34M | $-31M | $-51M | $-25M | $-54M | |
| CapEx | · | · | $11.0K | · | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $49.0K | $159.0K | $882.0K | $251.0K | |
| Investing Cash Flow | $41M | $32M | $22M | $67M | $53M | $37M | $16M | $20M | $-185M | $13M | $51M | $-43M | $12M | $15M | $-29M | $-58M | |
| Stock Issued | · | · | $0 | $0 | · | · | $0 | $0 | · | · | $0 | $0 | $38M | $-36.0K | $0 | $-4M | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | · | $-36.0K | · | · | |
| Financing Cash Flow | $1M | $380.0K | $715.0K | $0 | $373.0K | $0 | $2M | $1M | $262M | $1M | $248.0K | $112.0K | $39M | $2M | $-33M | $1M | |
| Taxes Paid | · | · | $0 | $0 | $-3M | $0 | $0 | $0 | $2M | $-4M | $-9M | $0 | $5M | $75.0K | $5M | $33M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | $-38M | · | · | · | $-51M | · | · |
Rentabilität 3
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -12.2% | -10.1% | · | -8.9% | -11.7% | -9.4% | · | -7.1% | -7.0% | -7.7% | · | -7.0% | -5.4% | -12.2% | · | -4.6% | |
| ROE | -13.2% | -10.8% | · | -9.4% | -12.2% | -9.9% | · | -7.4% | -7.3% | -8.2% | · | -7.4% | -5.8% | -12.8% | · | -4.8% | |
| ROIC | · | · | · | · | · | · | · | · | · | · | · | -9.7% | -7.5% | -12.9% | · | -4.6% |
Liquidität & Solvenz 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 8.4 | 10.3 | · | 10.4 | 9.8 | 11.6 | · | 24.5 | 28.9 | 20.3 | · | 20.3 | 25.3 | 15.2 | · | 21.5 | |
| Quick Ratio | 8.2 | 10.0 | · | 10.2 | 9.5 | 11.1 | · | 23.9 | 28.2 | 19.7 | · | 19.9 | 25.0 | 14.9 | · | 21.2 |
Effizienz 1
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 0.0 |
Bewertung (TTM) 9
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | |
| Net Income TTM | $-224M | $-219M | · | $-210M | $-201M | $-168M | · | $-159M | $-151M | $-167M | · | $-154M | $60M | $80M | · | $121M | |
| Market Cap | $1.17B | $873M | · | $350M | $445M | $444M | · | $973M | $1.01B | $734M | · | $387M | $460M | $402M | · | $586M | |
| P/E | -5.7 | -4.4 | · | -1.8 | -2.3 | -2.4 | · | -5.2 | -5.2 | -4.2 | · | -2.5 | 10.9 | 6.6 | · | 5.0 | |
| P/B | 3.6 | 2.4 | · | 0.8 | 0.9 | 0.8 | · | 1.6 | 1.5 | 1.7 | · | 0.8 | 0.9 | 0.8 | · | 1.0 | |
| P / Tangible Book | 3.6 | 2.4 | · | 0.8 | 0.9 | 0.8 | · | 1.6 | 1.5 | 1.7 | · | 0.8 | 0.9 | 0.8 | · | 1.0 | |
| P / Cash Flow | · | -19.0 | · | · | · | -10.3 | · | · | · | -19.2 | · | · | · | -7.9 | · | · | |
| P / FCF | · | · | · | · | · | · | · | · | · | -19.2 | · | · | · | -7.9 | · | · | |
| Earnings Yield | -17.6% | -22.6% | · | -54.1% | -42.6% | -42.4% | · | -19.2% | -19.1% | -23.5% | · | -40.8% | 9.2% | 15.0% | · | 20.0% |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Umsatz | — | — | — | $0 | $19M |
| Betriebsgewinnmarge % | — | — | — | — | -358.7% |
| Nettoergebnis | $-220M | $-167M | $-153M | $111M | $-66M |
| Verwässerte EPS | — | — | $-3.69 | $2.38 | $-1.52 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Liquiditätsgrad | 10.2 | 13.5 | 17.1 | 21.1 | 25.2 |
| Quick Ratio | 10.0 | 13.0 | 16.6 | 20.8 | 24.7 |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Freier Cashflow | $-176M | $-145M | $-134M | $-128M | — |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 199 Einreicher · $1.1B gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 39 (+5 vs. Vorquartal) | 19 (+4 vs. Vorquartal) | 73 (+12 vs. Vorquartal) | 47 (+7 vs. Vorquartal) | +11.3M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| MPM BIOIMPACT LLC | $177.207.720 | 9.731.341 | 16,33% | Aktien |
| Lynx1 Capital Management LP | $163.225.335 | 8.963.500 | 15,04% | Aktien |
| BVF INC/IL | $104.719.937 | 5.750.683 | 9,65% | Aktien |
| STATE STREET CORP | $66.805.698 | 3.668.627 | 6,16% | Aktien |
| Kynam Capital Management, LP | $56.708.344 | 3.114.132 | 5,23% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $47.602.142 | 2.614.066 | 4,39% | Aktien |
| RTW INVESTMENTS, LP | $43.054.759 | 2.364.347 | 3,97% | Aktien |
| Siren, L.L.C. | $34.478.996 | 1.893.410 | 3,18% | Aktien |
| Blue Owl Capital Holdings LP | $28.039.102 | 1.539.764 | 2,58% | Aktien |
| Venrock Adviser, LLC | $25.129.163 | 1.379.965 | 2,32% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $24.291.232 | 1.333.630 | 2,24% | Aktien |
| BOOTHBAY FUND MANAGEMENT, LLC | $19.714.346 | 1.082.611 | 1,82% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $17.886.827 | 982.253 | 1,65% | Aktien |
| GOLDMAN SACHS GROUP INC | $17.429.228 | 957.124 | 1,61% | Aktien |
| Affinity Asset Advisors, LLC | $15.947.590 | 875.760 | 1,47% | Aktien |
| Nextech Invest Ltd. | $13.899.146 | 1.141.145 | 1,28% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $13.452.474 | 738.741 | 1,24% | Aktien |
| BOONE CAPITAL MANAGEMENT LLC | $12.827.889 | 704.442 | 1,18% | Aktien |
| Elmind Capital, LP | $12.564.900 | 690.000 | 1,16% | Aktien |
| TWIN FOCUS CAPITAL PARTNERS, LLC | $10.843.855 | 595.489 | 1,00% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $8.450.059 | 464.034 | 0,78% | Aktien |
| PERCEPTIVE ADVISORS LLC | $7.766.164 | 426.478 | 0,72% | Aktien |
| TCG Crossover Management, LLC | $7.407.573 | 406.786 | 0,68% | Aktien |
| BANK OF AMERICA CORP /DE/ | $7.294.944 | 400.601 | 0,67% | Aktien |
| CITADEL ADVISORS LLC | $7.238.184 | 397.484 | 0,67% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $6.612.707 | 363.136 | 0,61% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $6.304.885 | 346.232 | 0,58% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $5.951.228 | 326.811 | 0,55% | Aktien |
| GREAT POINT PARTNERS LLC | $5.463.000 | 300.000 | 0,50% | Aktien |
| Connor, Clark & Lunn Investment Management Ltd. | $5.324.385 | 292.388 | 0,49% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $4.963.700 | 272.581 | 0,46% | Aktien |
| Bleichroeder LP | $4.552.500 | 250.000 | 0,42% | Aktien |
| FMR LLC | $4.370.036 | 239.980 | 0,40% | Aktien |
| JPMORGAN CHASE & CO | $4.357.638 | 236.571 | 0,40% | Aktien |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $4.333.980 | 238.000 | 0,40% | Aktien |
| Susquehanna Portfolio Strategies, LLC | $4.258.263 | 233.842 | 0,39% | Aktien |
| PFM Health Sciences, LP | $3.504.369 | 192.442 | 0,32% | Aktien |
| MOORE CAPITAL MANAGEMENT, LP | $3.458.917 | 189.946 | 0,32% | Aktien |
| Squarepoint Ops LLC | $3.061.411 | 168.117 | 0,28% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $2.846.533 | 156.317 | 0,26% | Aktien |
| Engineers Gate Manager LP | $2.787.041 | 153.050 | 0,26% | Aktien |
| Trexquant Investment LP | $2.770.888 | 152.163 | 0,26% | Aktien |
| BARCLAYS PLC | $2.555.756 | 140.349 | 0,24% | Aktien |
| PRUDENTIAL FINANCIAL INC | $2.266.326 | 124.455 | 0,21% | Aktien |
| CITIGROUP INC | $2.201.917 | 120.918 | 0,20% | Aktien |
| UBS Group AG | $2.023.350 | 111.112 | 0,19% | Aktien |
| Quantinno Capital Management LP | $2.000.842 | 109.876 | 0,18% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.576.986 | 86.600 | 0,15% | Kaufoption |
| Y-Intercept (Hong Kong) Ltd | $1.468.600 | 80.648 | 0,14% | Aktien |
| TD Asset Management Inc | $1.468.236 | 80.628 | 0,14% | Aktien |
| Apis Capital Advisors, LLC | $1.456.800 | 80.000 | 0,13% | Aktien |
| RHUMBLINE ADVISERS | $1.437.306 | 78.930 | 0,13% | Aktien |
| XTX Topco Ltd | $1.401.533 | 76.965 | 0,13% | Aktien |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $1.396.907 | 76.711 | 0,13% | Aktien |
| Swiss National Bank | $1.383.960 | 76.000 | 0,13% | Aktien |
| Point72 Asset Management, L.P. | $1.365.914 | 75.009 | 0,13% | Aktien |
| Mariner, LLC | $1.352.532 | 74.273 | 0,12% | Aktien |
| TWO SIGMA ADVISERS, LP | $1.343.523 | 129.809 | 0,12% | Aktien |
| Cubist Systematic Strategies, LLC | $1.318.345 | 222.318 | 0,12% | Aktien |
| Knott David M Jr | $1.259.804 | 69.182 | 0,12% | Aktien |
| Rafferty Asset Management, LLC | $1.203.535 | 66.092 | 0,11% | Aktien |
| MARSHALL WACE, LLP | $1.202.789 | 66.051 | 0,11% | Aktien |
| CITADEL ADVISORS LLC | $1.187.292 | 65.200 | 0,11% | Verkaufsoption |
| Longaeva Partners L.P. | $1.179.735 | 64.785 | 0,11% | Aktien |
| Bank of New York Mellon Corp | $1.158.921 | 63.642 | 0,11% | Aktien |
| MARTINGALE ASSET MANAGEMENT L P | $1.127.891 | 61.938 | 0,10% | Aktien |
| Assenagon Asset Management S.A. | $1.123.229 | 61.682 | 0,10% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $1.069.303 | 75.250 | 0,10% | Aktien |
| Corient Private Wealth LP | $970.267 | 53.282 | 0,09% | Aktien |
| KENNEDY CAPITAL MANAGEMENT LLC | $965.312 | 53.010 | 0,09% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $948.941 | 52.111 | 0,09% | Aktien |
| CITADEL ADVISORS LLC | $919.605 | 50.500 | 0,08% | Kaufoption |
| Soleus Capital Management, L.P. | $910.500 | 50.000 | 0,08% | Aktien |
| BlackRock, Inc. | $730.512 | 40.116 | 0,07% | Aktien |
| ALGERT GLOBAL LLC | $671.057 | 36.851 | 0,06% | Aktien |
| Vanguard Global Advisers, LLC | $669.709 | 36.777 | 0,06% | Aktien |
| JANE STREET GROUP, LLC | $668.307 | 36.700 | 0,06% | Verkaufsoption |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $655.560 | 36.000 | 0,06% | Verkaufsoption |
| Fisher Asset Management, LLC | $655.523 | 35.998 | 0,06% | Aktien |
| MetLife Investment Management, LLC | $650.935 | 35.746 | 0,06% | Aktien |
| IEQ CAPITAL, LLC | $614.041 | 33.720 | 0,06% | Aktien |
| PROFUND ADVISORS LLC | $608.269 | 33.403 | 0,06% | Aktien |
| VANGUARD ASSET MANAGEMENT, Ltd | $585.215 | 32.137 | 0,05% | Aktien |
| Leonteq Securities AG | $546.300 | 30.000 | 0,05% | Aktien |
| Verdad Advisers, LP | $527.853 | 28.987 | 0,05% | Aktien |
| ExodusPoint Capital Management, LP | $519.659 | 28.537 | 0,05% | Aktien |
| JANE STREET GROUP, LLC | $508.059 | 27.900 | 0,05% | Kaufoption |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $475.099 | 26.090 | 0,04% | Aktien |
| PANAGORA ASSET MANAGEMENT INC | $444.251 | 24.396 | 0,04% | Aktien |
| Invesco Ltd. | $438.060 | 24.056 | 0,04% | Aktien |
| Virtus Investment Advisers, LLC | $434.909 | 23.883 | 0,04% | Aktien |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $431.941 | 30.397 | 0,04% | Aktien |
| TUDOR INVESTMENT CORP ET AL | $410.053 | 22.518 | 0,04% | Aktien |
| Optimize Financial Inc | $400.125 | 28.158 | 0,04% | Aktien |
| MERCER GLOBAL ADVISORS INC /ADV | $399.200 | 21.922 | 0,04% | Aktien |
| NEW YORK STATE COMMON RETIREMENT FUND | $386.380 | 21.218 | 0,04% | Aktien |
| TEMA ETFS LLC | $382.577 | 36.964 | 0,04% | Aktien |
| AlphaCentric Advisors LLC | $371.957 | 20.426 | 0,03% | Aktien |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $370.537 | 20.348 | 0,03% | Aktien |
| STATE OF WISCONSIN INVESTMENT BOARD | $365.111 | 20.050 | 0,03% | Aktien |
Unternehmensinsider 23 Insider · 11 Führungskräfte · 12 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Nadim Ahmed | President and CEO | 24. Februar 2026 S | 390.803 | 0 | 3 | $-517.990 |
| Owen Hughes | President and CEO | 12. Januar 2021 P | 506.226 | 0 | 0 | $0 |
| Mary Kay Fenton | Chief Financial Officer | 30. Juni 2026 A | 127.921 | 0 | 1 | $-59.901 |
| Jeffrey Trigilio | Chief Financial Officer | 22. Februar 2024 A | 133.919 | 0 | 0 | $0 |
| Jacquelyn L Sumer | Chief Legal Officer | 30. Juni 2026 A | 130.559 | 0 | 3 | $-136.724 |
| Jeffrey Alan Jones | Chief Medical Officer | 24. Februar 2026 S | 159.968 | 0 | 3 | $-178.948 |
| Corrine Savill | Chief Business Officer | 18. Februar 2026 A | 240.990 | 0 | 0 | $0 |
| Patrick Baeuerle | Chief Scientific Officer | 17. Februar 2023 A | 76.000 | 0 | 0 | $0 |
| Leigh Zawel | Chief Scientific Officer, Small Molecules | 11. Februar 2022 A | 69.785 | 0 | 0 | $0 |
| Raymond T Keane | Chief Legal Officer | 11. Februar 2022 A | 24.124 | 0 | 0 | $0 |
| Jon Marc Wigginton | Chief Medical Officer | 7. Januar 2021 A | — | 0 | 0 | $0 |
| Mittie Doyle | Direktor | 16. Juni 2026 A | — | 0 | 0 | $0 |
| David D. Meek | Direktor | 16. Juni 2026 A | — | 0 | 0 | $0 |
| Anthony Rosenberg | Direktor | 16. Juni 2026 A | — | 0 | 0 | $0 |
| Stephen W Webster | Direktor | 16. Juni 2026 A | — | 0 | 0 | $0 |
| Andrew R Allen | Direktor | 16. Juni 2026 A | — | 0 | 0 | $0 |
| Mary Thistle | Direktor | 16. Juni 2026 A | — | 0 | 0 | $0 |
| David P. Ryan | Direktor | 12. Juni 2025 A | — | 0 | 0 | $0 |
| Anne-Marie Martin | Direktor | 12. Juni 2025 A | — | 0 | 0 | $0 |
| Thomas Ebeling | Direktor | 10. Juni 2024 M | 186.653 | 0 | 0 | $0 |
| ANSBERT GADICKE | Direktor | 22. Juni 2022 A | 7.648.268 | 0 | 0 | $0 |
| Morana Jovan-Embiricos | 10%-Eigentümer | 24. Juni 2022 M | 207.803 | 0 | 0 | $0 |
| Jennifer Michaelson | — | 13. August 2026 M | 162.844 | 0 | 17 | $-1.443.270 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 1 Beteiligung
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter | 19. Januar 2021 | — | Erste Einreichung | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 44 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 0,81% | 23.153 NS | 30. April 2026 | N-PORT |
| CANC · Tema ETF Trust | 0,59% | 62.826 NS | 31. Mai 2026 | N-PORT |
| IWC · iShares Trust | 0,25% | 205.875 SH | 8. August 2026 | Täglich |
| LABU · Direxion Shares ETF Trust | 0,19% | 74.789 NS | 30. April 2026 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0,10% | 114.553 SH | 8. August 2026 | Täglich |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,09% | 15.073 SH | 8. August 2026 | Täglich |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,08% | 133.270 NS | 31. Mai 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,07% | 3.344 SH | 8. August 2026 | Täglich |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,07% | 53.076 SH | 8. August 2026 | Täglich |
| IWN · iShares Trust | 0,07% | 565.284 SH | 8. August 2026 | Täglich |
| IBB · iShares Trust | 0,06% | 329.893 SH | 8. August 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,06% | 93.573 SH | 8. August 2026 | Täglich |
| SMLF · iShares Trust | 0,05% | 115.954 SH | 8. August 2026 | Täglich |
| BIB · ProShares Trust | 0,05% | 2.185 NS | 31. Mai 2026 | N-PORT |
| TMFX · RBB Fund, Inc. | 0,05% | 941 NS | 31. Mai 2026 | N-PORT |
| IWM · iShares Trust | 0,03% | 1.545.950 SH | 8. August 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,03% | 348.112 SH | 8. August 2026 | Täglich |
| ISCV · iShares Trust | 0,03% | 10.177 SH | 8. August 2026 | Täglich |
| ITWO · ProShares Trust | 0,02% | 2.539 NS | 31. Mai 2026 | N-PORT |
| RSSL · Global X Funds | 0,02% | 23.373 NS | 30. April 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,02% | 201.369 NS | 30. April 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,02% | 246.130 NS | 31. Mai 2026 | N-PORT |
| UWM · ProShares Trust | 0,01% | 1.986 NS | 31. Mai 2026 | N-PORT |
| ISCB · iShares Trust | 0,01% | 2.054 SH | 8. August 2026 | Täglich |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 621.038 SH | 8. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,01% | 113.923 SH | 8. August 2026 | Täglich |
| URTY · ProShares Trust | 0,01% | 2.013 NS | 31. Mai 2026 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0,01% | 5.216 NS | 31. Mai 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,01% | 14.784 NS | 30. April 2026 | N-PORT |
| WSML · iShares Trust | 0,01% | 2.213 SH | 8. August 2026 | Täglich |
| ONEQ · Fidelity Commonwealth Trust | 0,01% | 37.131 NS | 31. Mai 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 163.462 NS | 30. April 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,00% | 1.440 NS | 30. April 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,00% | 1.794 NS | 31. Mai 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 50 NS | 31. Mai 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 6.292 NS | 30. April 2026 | N-PORT |
| AVUS · AMERICAN CENTURY ETF TRUST | 0,00% | 15.101 NS | 31. Mai 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 16.447 NS | 30. April 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 16.841 SH | 8. August 2026 | Täglich |
| ITOT · iShares Trust | 0,00% | 72.685 SH | 8. August 2026 | Täglich |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 30.330 NS | 31. Mai 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 7.488 NS | 30. April 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1.929.766 SH | 8. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 4.664 SH | 8. August 2026 | Täglich |